A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants
Clinical trial NCT04330248 · COMPLETED
Trial details
- NCT number
- NCT04330248
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-31
- Primary completion
- 2022-06-14
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.